George Makhoul

Chief Executive Officer at Dilon Technologies

George Makhoul has worked in a variety of roles in the medical industry since 2000. George started as a Marketing Analyst at MORPACE Pharma Group in 2000 and then moved to Wyeth Pharmaceuticals in 2002 as a Territory Representative. In 2004, they joined Genzyme Biosurgery and held positions as Regional Key Account Manager, Biosurgical Specialist and Musculoskeletal Specialty Manager. In 2008, they were hired as Regional Sales Director at Precision Therapeutics, and then in 2011, they began working at Stryker as Director of Sales and Marketing, Orthobiologics and Director of Marketing, Orthobiologics, as well as Regional Manager. Most recently, they were Chief Executive Officer (CEO) and Chief Commercial Officer (CCO) at Biom'up USA, Inc from 2019 to 2022, and is currently Chief Executive Officer at Dilon Technologies Inc.

George Makhoul received their BA in Management from Moravian College, where they studied Business, Economics, Chemistry, Biosciences, and Biology.

Links

Previous companies

Stryker logo
Pfizer logo
Sanofi logo
Helomics logo

Timeline

  • Chief Executive Officer

    July, 2022 - present